Chang Xu

No ORCID on file · 5 papers in corpus
other 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01406-y

BACKGROUND: While the phenotypic link between body mass index (BMI) and some female reproductive disorders is well established, the genetic architecture and causal relationships have not been systematically studied. We aimed to create an at…

observational 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07850-2

PURPOSE: For unexpected low-prognosis patients (Group 1 and Group 2) defined by POSEIDON criteria, how to maximize the live birth rate while controlling the multiple birth rate by tailoring the embryo transfer number and quality? METHODS: …

other 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1438079

INTRODUCTION: Reproductive endocrine disorders (RED), including polycystic ovary syndrome (PCOS), endometriosis (EMs), and female infertility (FI), significantly affect women's health globally, with varying prevalence across different regio…

2024
·doi:10.21203/rs.3.rs-4207495/v1

Abstract Background Reproductive endocrine disorders (RED) including polycystic ovary syndrome (PCOS), endometriosis (EMs), and female infertility (FI), significantly affect women's health globally, with varying prevalence across different …

observational 2024
Journal of ovarian research ·doi:10.1186/s13048-024-01443-y

BACKGROUND: The 2016 Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria redefined the poor responders as low prognosis patients. The embryo transfer strategy for POSEIDON patients remained to be addresse…